IE39212B1 - New 1-substrotuted pyrazol 5-ones their production and their medicinal use - Google Patents
New 1-substrotuted pyrazol 5-ones their production and their medicinal useInfo
- Publication number
- IE39212B1 IE39212B1 IE798/74A IE79874A IE39212B1 IE 39212 B1 IE39212 B1 IE 39212B1 IE 798/74 A IE798/74 A IE 798/74A IE 79874 A IE79874 A IE 79874A IE 39212 B1 IE39212 B1 IE 39212B1
- Authority
- IE
- Ireland
- Prior art keywords
- lower alkyl
- alkyl
- amino
- trifluoromethyl
- alkenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
- C07D231/24—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms having sulfone or sulfonic acid radicals in the molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
- C07D231/52—Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Catalysts (AREA)
Abstract
1-Substituted pyrazol-5-ones of the formula ##SPC1## And pharmaceutically acceptable, nontoxic salts thereof, wherein R is hydrogen, amino, alkyl, alkenyl, phenyl or trifluoromethyl; R.sup.1 is hydrogen, alkyl, alkenyl, unsubstituted or substituted aryl or unsubstituted or substituted aralkyl; R.sup.2 is alkyl; and R.sup.3 is pyridyl, or aryl substituted by: A. 1 or 2 of the same or different substituents selected from the group consisting of halogen, trifluoromethyl, lower alkyl, lower alkenyl and lower alkoxy; B. cycloalkyl of 5, 6 or 7 carbon atoms or cycloalkenyl of 5, 6 or 7 carbon atoms; C. mono(lower alkyl)amino, di(lower alkyl)amino, trifluoromethoxy, nitro, cyano, carbamoyl, lower alkylcarbamoyl, di(lower alkyl)carbamoyl, sulphamyl, lower alkylsulphamyl, di(lower alkyl)sulphamyl, or --SO.sub.n lower alkyl wherein n is 0, 1 or 2; D. a member selected from the group consisting of mono(lower alkyl)amino, di(lower alkyl)amino, trifluoromethyl, nitro, cyano, carbamoyl, lower alkylcarbamoyl, di(lower alkyl)sulphamyl, and --SO.sub.n lower alkyl wherein n is 0, 1 or 2, and 1 or 2 of the same or different substituents selected from the group consisting of lower alkyl, lower alkenyl, lower alkoxy, halogen, and trifluoromethyl; or E. a fused, saturated or unsaturated 5-, 6-, or 7-membered ring or said ring containing 1 or 2 oxygen or sulphur atoms; Are useful for their diuretic, saluretic, antihypertensive and antithrombatic effects.[US3957814A]
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2319280A DE2319280A1 (en) | 1973-04-17 | 1973-04-17 | 1-Substd-pyrazol-5-ones - with diuretic, saluretic, antihypertensive and antithrombotic activity |
| DE2363139A DE2363139A1 (en) | 1973-12-19 | 1973-12-19 | 1-Substd-pyrazol-5-ones - with diuretic, saluretic, antihypertensive and antithrombotic activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE39212L IE39212L (en) | 1974-10-17 |
| IE39212B1 true IE39212B1 (en) | 1978-08-30 |
Family
ID=25764996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE798/74A IE39212B1 (en) | 1973-04-17 | 1974-04-17 | New 1-substrotuted pyrazol 5-ones their production and their medicinal use |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US3957814A (en) |
| JP (1) | JPS5314071B2 (en) |
| AR (5) | AR207444A1 (en) |
| AT (1) | AT337176B (en) |
| BG (5) | BG21405A3 (en) |
| CA (1) | CA1034953A (en) |
| CH (5) | CH603592A5 (en) |
| DD (1) | DD113757A5 (en) |
| DK (1) | DK136066C (en) |
| EG (1) | EG11157A (en) |
| ES (3) | ES425373A1 (en) |
| FI (1) | FI57587C (en) |
| FR (1) | FR2226172B1 (en) |
| GB (1) | GB1429141A (en) |
| HK (1) | HK70276A (en) |
| HU (1) | HU168590B (en) |
| IE (1) | IE39212B1 (en) |
| IL (1) | IL44626A (en) |
| LU (1) | LU69872A1 (en) |
| NL (1) | NL177917C (en) |
| NO (1) | NO138530C (en) |
| PH (1) | PH14829A (en) |
| PL (1) | PL96883B1 (en) |
| RO (2) | RO69740A (en) |
| SE (1) | SE408301B (en) |
| SU (2) | SU539525A3 (en) |
| YU (1) | YU104874A (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4056533A (en) * | 1973-04-17 | 1977-11-01 | Bayer Aktiengesellschaft | Pyrazol-5-ones |
| DE2526467A1 (en) * | 1975-06-13 | 1976-12-30 | Bayer Ag | 4-SUBSTITUTED PYRAZOLE DERIVATIVES, THE METHOD FOR THEIR MANUFACTURING AND THEIR USE AS A MEDICINAL PRODUCT |
| DE3306366A1 (en) * | 1983-02-24 | 1984-08-30 | Bayer Ag, 5090 Leverkusen | MEDICINAL PRODUCTS CONTAINING MUZOLIMIN, THE USE THEREOF AND METHOD FOR THE PRODUCTION THEREOF |
| US4663327A (en) * | 1984-05-23 | 1987-05-05 | Bayer Aktiengesellschaft | 1-heteroaryl-4-aryl-pyrazolin-5-ones |
| JPH0730031B2 (en) * | 1986-04-02 | 1995-04-05 | 日産化学工業株式会社 | Process for producing 2-pyrazolin-5-ones |
| DE3738963A1 (en) * | 1987-11-17 | 1989-05-24 | Bayer Ag | 3-AMINOPYRAZOLINE-5-ONE |
| GB8912861D0 (en) * | 1989-06-05 | 1989-07-26 | Sherritt Gordon Ltd | Purification of elemental sulphur |
| US5711929A (en) * | 1989-05-06 | 1998-01-27 | 698638 Alberta Ltd. | Purification of elemental sulphur |
| JPH079410Y2 (en) * | 1989-05-08 | 1995-03-06 | 株式会社アンレット | Roots blower for carbon dioxide laser beam oscillator |
| US5300514A (en) * | 1990-07-17 | 1994-04-05 | Eli Lilly And Company | Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof |
| US5399565A (en) * | 1990-07-17 | 1995-03-21 | Eli Lilly And Company | Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations therof |
| EP0478195B1 (en) * | 1990-09-21 | 1999-05-26 | Rohm And Haas Company | Dihydropyridazinones and pyridazinones as fungicides |
| CN1038249C (en) * | 1991-08-28 | 1998-05-06 | 罗姆和哈斯公司 | Dihydropyridazinones, pyridazinones and related compounds as fungicides |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2376380A (en) * | 1945-05-22 | Preparation of amino pyrazolones | ||
| GB636988A (en) * | 1947-12-24 | 1950-05-10 | Gevaert Photo Producten Naamlo | Improvements in and relating to the production of colour photographic images |
| US2511231A (en) * | 1949-03-26 | 1950-06-13 | Eastman Kodak Co | 1-cyanophenyl-3-acylamino-5-pyrazolone couplers for color photography |
| US2600788A (en) * | 1949-06-07 | 1952-06-17 | Eastman Kodak Co | Halogen-substituted pyrazolone couplers for color photography |
| US2672417A (en) * | 1949-12-31 | 1954-03-16 | Gevaert Photo Prod Nv | Production of color photographic images |
| NL121416C (en) * | 1961-05-31 |
-
1974
- 1974-01-01 AR AR253331A patent/AR207444A1/en active
- 1974-03-29 FR FR7411495A patent/FR2226172B1/fr not_active Expired
- 1974-04-09 HU HUBA3058A patent/HU168590B/hu unknown
- 1974-04-11 FI FI1105/74A patent/FI57587C/en active
- 1974-04-12 BG BG027980A patent/BG21405A3/en unknown
- 1974-04-12 BG BG027979A patent/BG22821A3/en unknown
- 1974-04-12 IL IL44626A patent/IL44626A/en unknown
- 1974-04-12 BG BG027978A patent/BG21218A3/en unknown
- 1974-04-12 BG BG026395A patent/BG21217A3/en unknown
- 1974-04-12 BG BG027977A patent/BG21857A3/en unknown
- 1974-04-15 RO RO7485201A patent/RO69740A/en unknown
- 1974-04-15 PH PH15730A patent/PH14829A/en unknown
- 1974-04-15 YU YU01048/74A patent/YU104874A/en unknown
- 1974-04-15 JP JP4111274A patent/JPS5314071B2/ja not_active Expired
- 1974-04-15 RO RO7400078420A patent/RO63749A/en unknown
- 1974-04-15 DD DD177913A patent/DD113757A5/xx unknown
- 1974-04-15 US US05/461,282 patent/US3957814A/en not_active Expired - Lifetime
- 1974-04-16 ES ES425373A patent/ES425373A1/en not_active Expired
- 1974-04-16 EG EG119/74A patent/EG11157A/en active
- 1974-04-16 AT AT313274A patent/AT337176B/en not_active IP Right Cessation
- 1974-04-16 CH CH524274A patent/CH603592A5/xx not_active IP Right Cessation
- 1974-04-16 CH CH156577A patent/CH605800A5/xx not_active IP Right Cessation
- 1974-04-16 NL NLAANVRAGE7405115,A patent/NL177917C/en not_active IP Right Cessation
- 1974-04-16 LU LU69872A patent/LU69872A1/xx unknown
- 1974-04-16 CH CH156677A patent/CH605797A5/xx not_active IP Right Cessation
- 1974-04-16 CH CH156477A patent/CH605801A5/xx not_active IP Right Cessation
- 1974-04-16 SE SE7405078A patent/SE408301B/en not_active IP Right Cessation
- 1974-04-16 NO NO741365A patent/NO138530C/en unknown
- 1974-04-16 CH CH156377A patent/CH596172A5/xx not_active IP Right Cessation
- 1974-04-16 DK DK208074A patent/DK136066C/en not_active IP Right Cessation
- 1974-04-16 PL PL1974170378A patent/PL96883B1/en unknown
- 1974-04-16 GB GB1650774A patent/GB1429141A/en not_active Expired
- 1974-04-17 CA CA197,660A patent/CA1034953A/en not_active Expired
- 1974-04-17 IE IE798/74A patent/IE39212B1/en unknown
-
1975
- 1975-01-01 AR AR258506A patent/AR208192A1/en active
- 1975-01-01 AR AR258508A patent/AR205272A1/en active
- 1975-01-01 AR AR258507A patent/AR205271A1/en active
- 1975-03-19 SU SU2115103A patent/SU539525A3/en active
- 1975-03-19 SU SU2114308A patent/SU541430A3/en active
- 1975-04-25 AR AR258505A patent/AR204951A1/en active
-
1976
- 1976-04-15 ES ES447063A patent/ES447063A1/en not_active Expired
- 1976-04-15 ES ES447064A patent/ES447064A1/en not_active Expired
- 1976-11-11 HK HK702/76*UA patent/HK70276A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE39212B1 (en) | New 1-substrotuted pyrazol 5-ones their production and their medicinal use | |
| IE38730B1 (en) | Heterocyclic containing sulphoxides | |
| ES8601934A1 (en) | Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same. | |
| IE39211B1 (en) | Diuretic and antihypertensive medicines comprising pyrazololone derivatives | |
| GB1488692A (en) | Pyrazolo(3,4,6)quinolines | |
| GB1441859A (en) | Pyrazole derivatives process for tbeir preparation and their use as medicaments | |
| GB1501565A (en) | 1-substituted pyrazole derivatives processes for their preparation and their use as medicaments | |
| GB1424492A (en) | Pyrazol-5-ones their preparation and their pharmaceutical use | |
| GB1432816A (en) | Pharmaceutical antimycotic compositions medicaments and method | |
| ES426663A1 (en) | Triazolo isoindole derivatives | |
| GB1462036A (en) | Aminoindane derivatives | |
| DE3264708D1 (en) | 4-aryloxy-1,2,3,4-tetrahydroisoquinolines, and intermediates, a process for preparing the same, a pharmaceutical composition containing the same and their use as medicaments | |
| GB1530770A (en) | 2,4-imidazolidinedione derivatives and preparation thereo | |
| GB1497729A (en) | Benzenesulphonyl ureas and process for their manufacture | |
| GB1320453A (en) | Aromatic diethers | |
| EP0386669A3 (en) | Color light-sensitive material | |
| GB1513702A (en) | 4-substituted pyrazole derivatives processes for their preparation and their use as medicaments | |
| GB1462521A (en) | Triazole derivatives | |
| GB1297401A (en) | ||
| GB1495034A (en) | Pharmaceutical compositions | |
| GB1254270A (en) | Benzoxazepine derivatives | |
| IE41222B1 (en) | New 1-aryl-uracils their production and their medicinal use | |
| IE40182L (en) | Aminoethanol derivatives | |
| SE7501871L (en) | ||
| GB1394794A (en) | Substituted benzhydryl lactamimide derivatives |